Annals of Hematology

Springer

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Annals of Hematology is an open-access journal published by Springer in Germany, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 3,590 EUR. Declared review time at DOAJ: 18 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer
ISSN
0939-5555 · 1432-0584
Country
Germany
Languages
english
Access
Open access
Declared publication charge
3,590 EUR
Articles in DOAJ
492
Declared review time
18 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2025-11-24
  • MEDLINE · 1991-01-01
Indexing
DOAJ · MEDLINE
APC
3,590 EUR
Declared review time (DOAJ)
18 weeks
Actual review time (measured)
90 days received→accepted — computed from PubMed (n=99)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

492

Most recent article

last month

Average review time (journal-declared via DOAJ)

18weeks

Works in OpenAlex

13718

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

114

i10-index

4956

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2025-11-24
Added to DOAJ
2025-11-24
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
Portico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
92%
ORCID iDs in current deposits
31%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
9107334
Classification2

Subjects (DOAJ)

Medicine: Internal medicine

LCC codes

RC31-1245

Subject areas

  • Acute Myeloid Leukemia Research
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cell Transplantation
Show all subjects (50)
  • Hemoglobinopathies and Related Disorders
  • Hemoglobinopathies and Related Disorders
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia research
  • Acute Lymphoblastic Leukemia research
  • Blood groups and transfusion
  • Blood groups and transfusion
  • Multiple Myeloma Research and Treatments
  • Multiple Myeloma Research and Treatments
  • Platelet Disorders and Treatments
  • Platelet Disorders and Treatments
  • Viral-associated cancers and disorders
  • Viral-associated cancers and disorders
  • Erythrocyte Function and Pathophysiology
  • Erythrocyte Function and Pathophysiology
  • Iron Metabolism and Disorders
  • Blood disorders and treatments
  • Blood disorders and treatments
  • Iron Metabolism and Disorders
  • Medical and Health Sciences Research
  • Medical and Health Sciences Research
  • Immune Cell Function and Interaction
  • Immune Cell Function and Interaction
  • CNS Lymphoma Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Eosinophilic Disorders and Syndromes
  • Eosinophilic Disorders and Syndromes
  • Neutropenia and Cancer Infections
  • Neutropenia and Cancer Infections
  • Immunodeficiency and Autoimmune Disorders
  • Immunodeficiency and Autoimmune Disorders
  • Retinoids in leukemia and cellular processes
  • Hematological disorders and diagnostics
  • Hematological disorders and diagnostics
  • Retinoids in leukemia and cellular processes
  • Blood properties and coagulation
  • Blood properties and coagulation
  • CAR-T cell therapy research
  • CAR-T cell therapy research

Keywords (DOAJ)

  • hematology
  • blood cancer

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: